Exponent (EXPO) Financials

$76.98 -0.26 (-0.34%)

As of 09:58 AM Eastern

Annual Income Statements for Exponent

This table shows Exponent's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Net Income / (Loss) Attributable to Common Shareholders	109	100	102	101	83	82	72	41	47	44
Consolidated Net Income / (Loss)	109	100	102	101	83	82	72	41	47	44
Net Income / (Loss) Continuing Operations	109	100	102	101	83	82	72	41	47	44
Total Pre-Tax Income	147	136	132	126	97	104	93	83	69	71
Total Operating Income	120	111	141	109	83	85	91	72	62	69
Total Gross Profit	229	217	249	188	150	165	164	138	122	128
Total Revenue	559	537	513	466	400	417	380	348	315	313
Operating Revenue	559	537	513	466	400	417	380	348	315	313
Total Cost of Revenue	330	320	264	278	250	252	215	210	193	185
Operating Cost of Revenue	330	320	264	278	250	252	215	210	193	185
Total Operating Expenses	109	106	108	79	67	80	73	65	60	59
Selling, General & Admin Expense	69	66	59	48	45	54	48	47	44	42
Other Operating Expenses / (Income)	40	40	49	31	21	26	25	18	16	17
Total Other Income / (Expense), net	28	25	-8.61	17	14	19	1.86	10	7.21	2.20
Interest & Investment Income	10	7.15	2.10	0.07	1.71	3.91	2.75	1.29	0.68	0.21
Other Income / (Expense), net	18	17	-11	17	12	15	-0.89	9.16	6.53	1.99
Income Tax Expense	38	36	30	25	14	22	21	41	22	28
Basic Earnings per Share	$2.13	$1.96	$1.98	$1.92	$1.58	$1.56	$1.37	$0.78	$0.90	$1.64
Weighted Average Basic Shares Outstanding	51.13M	51.15M	51.73M	52.61M	52.39M	52.69M	52.91M	52.72M	52.98M	26.61M
Diluted Earnings per Share	$2.11	$1.94	$1.96	$1.90	$1.55	$1.53	$1.33	$0.77	$0.87	$1.60
Weighted Average Diluted Shares Outstanding	51.57M	51.64M	52.28M	53.33M	53.32M	53.88M	54.17M	53.97M	54.33M	27.30M
Weighted Average Basic & Diluted Shares Outstanding	50.82M	50.56M	50.64M	52.12M	51.80M	51.82M	52.70M	53M	26.50M	26.60M
Cash Dividends to Common per Share	$1.12	$1.04	$0.96	$0.80	$0.76	$0.64	$0.52	$0.42	$0.36	$0.60

This table shows Exponent's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/3/2025	9/27/2024	6/28/2024	3/29/2024	12/29/2023	9/29/2023	6/30/2023	3/31/2023	12/30/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	24	26	29	30	21	25	26	29	23	24
Consolidated Net Income / (Loss)	24	26	29	30	21	25	26	29	23	24
Net Income / (Loss) Continuing Operations	24	26	29	30	21	25	26	29	23	24
Total Pre-Tax Income	31	36	40	40	30	34	36	36	31	33
Total Operating Income	27	26	36	31	18	34	30	29	22	37
Total Gross Profit	59	54	61	55	44	59	57	56	53	64
Total Revenue	137	136	141	145	123	133	140	140	127	127
Operating Revenue	137	136	141	145	123	133	140	140	127	127
Total Cost of Revenue	78	82	79	90	79	74	83	84	74	63
Operating Cost of Revenue	78	82	79	90	79	74	83	84	74	63
Total Operating Expenses	31	28	25	24	26	25	28	27	31	28
Selling, General & Admin Expense	18	17	17	16	17	17	17	15	16	16
Other Operating Expenses / (Income)	13	11	8.10	7.73	9.03	8.38	11	12	15	12
Total Other Income / (Expense), net	4.08	10	3.94	9.71	12	0.08	6.38	6.42	8.48	-3.34
Interest & Investment Income	2.59	2.56	2.23	2.63	1.93	1.86	1.59	1.77	1.26	0.64
Other Income / (Expense), net	1.49	7.53	1.71	7.08	9.77	-1.77	4.79	4.65	7.22	-3.98
Income Tax Expense	7.74	9.89	10	10	9.16	9.48	11	6.41	8.00	9.03
Basic Earnings per Share	$0.46	$0.51	$0.57	$0.59	$0.41	$0.48	$0.50	$0.57	$0.45	$0.47
Weighted Average Basic Shares Outstanding	51.13M	51.18M	51.11M	51.01M	51.15M	51.20M	51.26M	51.13M	51.73M	51.49M
Diluted Earnings per Share	$0.45	$0.50	$0.57	$0.59	$0.40	$0.48	$0.50	$0.56	$0.44	$0.47
Weighted Average Diluted Shares Outstanding	51.57M	51.62M	51.52M	51.42M	51.64M	51.65M	51.69M	51.68M	52.28M	52.01M
Weighted Average Basic & Diluted Shares Outstanding	50.82M	50.76M	50.73M	50.67M	50.56M	50.62M	50.85M	50.84M	50.64M	50.64M
Cash Dividends to Common per Share	$0.28	$0.28	$0.28	$0.28	$0.26	$0.26	$0.26	$0.26	$0.24	$0.24

This table details how cash moves in and out of Exponent's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Net Change in Cash & Equivalents	72	26	-136	100	21	49	2.27	9.83	-11	-3.74
Net Cash From Operating Activities	145	127	94	125	103	108	91	68	67	60
Net Cash From Continuing Operating Activities	145	127	94	125	103	108	91	68	67	60
Net Income / (Loss) Continuing Operations	109	100	102	101	83	82	72	41	47	44
Consolidated Net Income / (Loss)	109	100	102	101	83	82	72	41	47	44
Depreciation Expense	9.69	8.92	7.08	6.49	6.87	6.81	6.29	6.29	6.13	5.48
Amortization Expense	0.00	0.00	0.00	-0.01	-0.16	-0.52	-0.11	0.00	0.00	0.60
Non-Cash Adjustments To Reconcile Net Income	28	24	23	21	19	20	19	18	16	7.49
Changes in Operating Assets and Liabilities, net	-1.84	-5.49	-39	-4.33	-5.08	-0.38	-6.26	1.95	-2.45	3.32
Net Cash From Investing Activities	-6.94	-16	-12	38	5.02	4.27	-26	-18	-27	-27
Net Cash From Continuing Investing Activities	-6.94	-16	-12	38	5.02	4.27	-26	-18	-27	-27
Purchase of Property, Plant & Equipment	-6.94	-16	-12	-6.83	-4.99	-23	-16	-4.73	-14	-5.38
Purchase of Investments	0.00	0.00	0.00	-35	-40	-39	-53	-29	-51	-44
Sale and/or Maturity of Investments	0.00	0.00	0.00	80	50	66	43	16	38	22
Net Cash From Financing Activities	-65	-86	-216	-63	-88	-63	-63	-41	-49	-37
Net Cash From Continuing Financing Activities	-65	-86	-216	-63	-88	-63	-63	-41	-49	-37
Repurchase of Common Equity	-5.71	-24	-156	-7.00	-40	-22	-28	-12	-24	-23
Payment of Dividends	-58	-54	-49	-43	-40	-34	-27	-22	-19	-16
Issuance of Common Equity	5.74	2.18	2.02	3.11	6.73	3.23	1.47	2.03	1.76	3.01
Other Financing Activities, net	-6.92	-9.94	-13	-16	-15	-11	-8.84	-9.52	-7.69	-0.97
Effect of Exchange Rate Changes	-0.74	0.71	-2.02	0.17	1.11	0.46	-0.60	0.97	-1.12	-0.28

This table details how cash moves in and out of Exponent's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/3/2025	9/27/2024	6/28/2024	3/29/2024	12/29/2023	9/29/2023	6/30/2023	3/31/2023	12/30/2022	9/30/2022
Net Change in Cash & Equivalents	39	16	35	-18	50	-11	23	-36	13	-17
Net Cash From Operating Activities	56	30	48	10	71	22	41	-6.70	41	29
Net Cash From Continuing Operating Activities	56	30	48	10	71	22	41	-6.70	41	29
Net Income / (Loss) Continuing Operations	24	26	29	30	21	25	26	29	23	24
Consolidated Net Income / (Loss)	24	26	29	30	21	25	26	29	23	24
Depreciation Expense	2.49	2.39	2.49	2.32	2.38	2.36	2.19	1.99	1.86	1.72
Non-Cash Adjustments To Reconcile Net Income	6.17	6.25	6.66	8.62	4.49	5.52	5.62	7.96	5.26	5.25
Changes in Operating Assets and Liabilities, net	24	-4.97	9.97	-31	44	-10	6.99	-46	11	-1.99
Net Cash From Investing Activities	-2.60	-1.71	-1.15	-1.48	-1.93	-3.31	-5.45	-5.67	-2.94	-3.19
Net Cash From Continuing Investing Activities	-2.60	-1.71	-1.15	-1.48	-1.93	-3.31	-5.45	-5.67	-2.94	-3.19
Purchase of Property, Plant & Equipment	-2.60	-1.71	-1.15	-1.48	-1.93	-3.31	-5.45	-5.67	-2.94	-3.19
Net Cash From Financing Activities	-12	-13	-13	-27	-20	-30	-13	-24	-25	-42
Net Cash From Continuing Financing Activities	-12	-13	-13	-27	-20	-30	-13	-24	-25	-42
Repurchase of Common Equity	-0.00	0.00	-0.24	-5.47	-7.24	-17	-	0.00	-14	-30
Payment of Dividends	-14	-14	-14	-16	-13	-13	-13	-15	-12	-12
Issuance of Common Equity	2.00	1.29	1.84	0.62	0.37	0.57	0.56	0.68	0.39	0.56
Other Financing Activities, net	-0.09	-0.03	-	-6.80	-0.02	-	-	-9.92	-	-
Effect of Exchange Rate Changes	-1.94	1.41	0.01	-0.21	0.71	-0.39	0.08	0.30	0.80	-1.38

This table presents Exponent's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Total Assets	777	647	587	684	580	563	469	440	404	388
Total Current Assets	447	380	349	453	367	364	327	316	274	273
Cash & Equivalents	259	187	161	298	198	176	127	125	115	126
Accounts Receivable	161	167	170	140	112	120	106	110	87	89
Prepaid Expenses	27	25	18	15	13	12	12	9.01	13	13
Plant, Property, & Equipment, net	73	75	66	60	60	62	46	35	37	28
Total Noncurrent Assets	257	192	172	171	153	138	96	89	93	86
Goodwill	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61	8.61
Noncurrent Deferred & Refundable Income Taxes	57	54	54	47	41	37	34	30	42	39
Other Noncurrent Operating Assets	192	129	109	116	104	92	54	1.35	1.06	1.65
Total Liabilities & Shareholders' Equity	777	647	587	684	580	563	469	440	404	388
Total Liabilities	356	291	266	267	219	213	155	151	130	125
Total Current Liabilities	163	162	159	153	117	124	98	93	80	80
Accounts Payable	22	22	29	25	16	19	12	15	10	11
Current Deferred Revenue	16	22	19	20	12	13	9.17	8.30	7.62	7.80
Current Employee Benefit Liabilities	119	112	106	104	83	87	77	70	63	62
Other Current Liabilities	5.39	6.30	5.26	5.16	5.99	5.94	0.00	-	-	-
Total Noncurrent Liabilities	193	129	107	114	101	89	57	57	50	44
Noncurrent Employee Benefit Liabilities	113	103	91	101	84	68	53	53	47	40
Other Noncurrent Operating Liabilities	80	25	16	13	2.99	21	2.55	3.33	2.01	1.91
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	421	356	321	417	361	350	314	289	273	263
Total Preferred & Common Equity	421	356	321	417	361	350	314	289	273	263
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	421	356	321	417	360	348	311	289	273	263
Common Stock	346	322	301	281	265	245	227	210	195	180
Retained Earnings	624	574	529	478	422	385	342	304	291	269
Treasury Stock	-545	-537	-506	-341	-324	-278	-253	-223	-209	-184
Accumulated Other Comprehensive Income / (Loss)	-3.79	-2.98	-3.59	-1.98	-3.86	-3.52	-5.71	-2.03	-3.13	-1.81

This table presents Exponent's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/27/2024	6/28/2024	3/29/2024	9/29/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	744	709	629	602	604	566	559
Total Current Assets	413	391	352	343	345	318	333
Cash & Equivalents	220	203	169	137	148	126	148
Accounts Receivable	169	166	163	182	176	173	166
Prepaid Expenses	24	22	21	24	21	20	18
Plant, Property, & Equipment, net	73	73	75	76	77	69	64
Total Noncurrent Assets	259	245	203	183	183	179	162
Goodwill	8.61	8.61	8.61	8.61	8.61	8.61	8.61
Noncurrent Deferred & Refundable Income Taxes	54	52	52	54	52	52	51
Other Noncurrent Operating Assets	196	185	142	120	122	118	103
Total Liabilities & Shareholders' Equity	744	709	629	602	604	566	559
Total Liabilities	334	316	255	249	247	225	239
Total Current Liabilities	138	132	114	130	125	109	138
Accounts Payable	23	22	24	20	20	26	32
Current Deferred Revenue	13	14	16	10	11	15	16
Current Employee Benefit Liabilities	97	91	68	94	88	63	85
Other Current Liabilities	4.94	4.90	5.81	5.70	5.75	4.90	5.36
Total Noncurrent Liabilities	196	184	141	119	123	115	101
Noncurrent Employee Benefit Liabilities	116	109	116	93	96	101	85
Other Noncurrent Operating Liabilities	81	76	25	26	26	14	16
Total Equity & Noncontrolling Interests	410	393	374	354	357	342	320
Total Preferred & Common Equity	410	393	374	354	357	342	320
Total Common Equity	410	393	374	354	357	342	320
Common Stock	342	339	335	320	317	315	299
Retained Earnings	615	603	589	567	555	543	519
Treasury Stock	-545	-546	-546	-529	-512	-513	-492
Accumulated Other Comprehensive Income / (Loss)	-1.61	-3.17	-3.19	-3.78	-3.26	-3.13	-5.14

This table displays calculated financial ratios and metrics derived from Exponent's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	1/3/2025	12/29/2023	12/30/2022	12/31/2021	1/1/2021	1/3/2020	12/28/2018	12/29/2017	12/30/2016	1/1/2016
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.05%	4.57%	10.09%	16.60%	-4.15%	9.93%	9.12%	10.39%	0.72%	2.67%
EBITDA Growth	6.83%	0.32%	3.76%	29.73%	-4.34%	10.15%	10.56%	17.34%	-3.15%	3.91%
EBIT Growth	6.70%	-1.07%	3.47%	32.07%	-5.03%	10.72%	11.51%	18.67%	-3.51%	4.59%
NOPAT Growth	7.59%	-24.59%	24.42%	23.56%	5.25%	-4.88%	96.32%	-15.18%	0.65%	11.02%
Net Income Growth	8.63%	-1.95%	1.11%	22.59%	0.11%	14.13%	74.93%	-13.01%	8.90%	7.12%
EPS Growth	8.76%	-1.02%	3.16%	22.58%	1.31%	15.04%	72.73%	-13.01%	8.90%	8.84%
Operating Cash Flow Growth	13.49%	35.76%	-24.69%	20.57%	-4.39%	18.50%	34.42%	1.33%	10.67%	25.36%
Free Cash Flow Firm Growth	31.21%	5.04%	-31.97%	80.58%	4.01%	-7.02%	35.22%	26.06%	-16.64%	50.95%
Invested Capital Growth	-4.01%	6.05%	33.44%	-10.45%	12.36%	12.62%	13.66%	-6.96%	9.22%	1.48%
Revenue Q/Q Growth	2.55%	-0.82%	2.77%	2.25%	-1.69%	4.50%	1.03%	3.35%	1.07%	0.02%
EBITDA Q/Q Growth	0.47%	-0.41%	0.68%	1.45%	0.68%	5.00%	0.75%	4.30%	1.06%	-0.02%
EBIT Q/Q Growth	0.43%	-0.85%	0.47%	1.63%	0.88%	4.99%	0.80%	4.78%	1.02%	0.16%
NOPAT Q/Q Growth	9.77%	-4.38%	-0.25%	2.46%	-0.92%	-6.89%	50.57%	-26.07%	1.08%	1.38%
Net Income Q/Q Growth	2.50%	-1.56%	2.14%	-1.42%	3.41%	3.89%	37.59%	-25.44%	1.15%	1.41%
EPS Q/Q Growth	2.43%	-2.02%	3.16%	-1.55%	1.31%	2.00%	34.34%	-25.44%	1.15%	-1.23%
Operating Cash Flow Q/Q Growth	-9.55%	31.82%	-12.68%	11.98%	-12.61%	11.80%	3.98%	19.69%	5.57%	7.09%
Free Cash Flow Firm Q/Q Growth	-10.64%	77.91%	-30.10%	34.97%	-35.22%	55.61%	9.24%	40.04%	9.46%	16.60%
Invested Capital Q/Q Growth	-14.90%	-21.98%	-7.04%	-25.81%	-11.50%	-28.48%	-17.87%	-31.08%	-14.42%	-13.54%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	40.91%	40.40%	48.52%	40.37%	37.47%	39.55%	43.34%	39.54%	38.62%	41.02%
EBITDA Margin	26.33%	25.65%	26.73%	28.36%	25.49%	25.54%	25.49%	25.16%	23.67%	24.61%
Operating Margin	21.41%	20.74%	27.44%	23.36%	20.82%	20.40%	24.10%	20.72%	19.65%	22.04%
EBIT Margin	24.60%	23.99%	25.35%	26.97%	23.81%	24.04%	23.86%	23.35%	21.72%	22.67%
Profit (Net Income) Margin	19.52%	18.69%	19.94%	21.70%	20.64%	19.77%	19.04%	11.88%	15.07%	13.94%
Tax Burden Percent	73.96%	73.84%	77.39%	80.42%	85.16%	79.14%	77.43%	50.06%	68.69%	61.29%
Interest Burden Percent	107.28%	105.55%	101.61%	100.05%	101.79%	103.90%	103.04%	101.59%	101.00%	100.29%
Effective Tax Rate	26.04%	26.16%	22.61%	19.58%	14.84%	20.86%	22.57%	49.94%	31.31%	38.71%
Return on Invested Capital (ROIC)	53.42%	50.08%	78.22%	69.34%	56.27%	60.14%	71.51%	37.51%	44.57%	46.66%
ROIC Less NNEP Spread (ROIC-NNEP)	44.19%	39.67%	81.12%	64.16%	51.20%	53.28%	70.80%	34.68%	41.70%	45.83%
Return on Net Nonoperating Assets (RNNOA)	-25.36%	-20.43%	-50.48%	-43.34%	-33.08%	-35.31%	-47.55%	-22.82%	-26.86%	-29.47%
Return on Equity (ROE)	28.05%	29.65%	27.74%	26.00%	23.20%	24.83%	23.97%	14.69%	17.71%	17.20%
Cash Return on Invested Capital (CROIC)	57.50%	44.21%	49.57%	80.37%	44.63%	48.27%	58.72%	44.72%	35.75%	45.20%
Operating Return on Assets (OROA)	19.29%	20.88%	20.49%	19.90%	16.66%	19.43%	19.94%	19.26%	17.30%	18.84%
Return on Assets (ROA)	15.31%	16.27%	16.11%	16.02%	14.44%	15.98%	15.91%	9.80%	12.00%	11.58%
Return on Common Equity (ROCE)	28.05%	29.65%	27.74%	25.93%	23.08%	24.66%	23.85%	14.69%	17.71%	17.20%
Return on Equity Simple (ROE_SIMPLE)	25.89%	28.18%	31.90%	24.27%	22.84%	23.54%	23.02%	14.29%	17.37%	16.59%
Net Operating Profit after Tax (NOPAT)	88	82	109	88	71	67	71	36	43	42
NOPAT Margin	15.83%	15.31%	21.23%	18.79%	17.73%	16.15%	18.66%	10.37%	13.50%	13.51%
Net Nonoperating Expense Percent (NNEP)	9.22%	10.41%	-2.90%	5.17%	5.07%	6.86%	0.71%	2.83%	2.87%	0.83%
Return On Investment Capital (ROIC_SIMPLE)	21.00%	23.08%	33.98%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	59.09%	59.60%	51.48%	59.63%	62.53%	60.45%	56.66%	60.46%	61.38%	58.98%
SG&A Expenses to Revenue	12.34%	12.29%	11.44%	10.27%	11.28%	12.96%	12.68%	13.61%	13.93%	13.51%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	19.51%	19.67%	21.08%	17.01%	16.66%	19.15%	19.24%	18.82%	18.97%	18.99%
Earnings before Interest and Taxes (EBIT)	137	129	130	126	95	100	91	81	68	71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	147	138	137	132	102	107	97	88	75	77
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	10.72	12.37	15.28	14.19	12.48	10.02	7.90	5.95	5.22	4.46
Price to Tangible Book Value (P/TBV)	10.94	12.67	15.71	14.48	12.78	10.27	8.12	6.13	5.39	4.61
Price to Revenue (P/Rev)	8.08	8.20	9.55	12.69	11.22	8.37	6.47	4.94	4.53	3.75
Price to Earnings (P/E)	41.41	43.89	47.91	58.46	54.34	42.33	33.99	41.62	30.05	26.91
Dividend Yield	1.26%	1.20%	0.99%	0.70%	0.87%	0.95%	0.96%	1.26%	1.29%	1.32%
Earnings Yield	2.42%	2.28%	2.09%	1.71%	1.84%	2.36%	2.94%	2.40%	3.33%	3.72%
Enterprise Value to Invested Capital (EV/IC)	26.24	24.96	29.76	47.07	31.94	27.46	21.33	16.43	12.58	10.98
Enterprise Value to Revenue (EV/Rev)	7.62	7.86	9.24	12.05	10.65	7.81	5.92	4.38	3.98	3.20
Enterprise Value to EBITDA (EV/EBITDA)	28.93	30.63	34.55	42.49	41.77	30.58	23.23	17.40	16.80	13.01
Enterprise Value to EBIT (EV/EBIT)	30.97	32.75	36.43	44.67	44.71	32.50	24.81	18.75	18.31	14.12
Enterprise Value to NOPAT (EV/NOPAT)	48.11	51.30	43.50	64.14	60.06	48.38	31.74	42.21	29.46	23.70
Enterprise Value to Operating Cash Flow (EV/OCF)	29.44	33.11	50.54	45.11	41.21	30.16	24.64	22.44	18.72	16.56
Enterprise Value to Free Cash Flow (EV/FCFF)	44.69	58.12	68.63	55.34	75.72	60.27	38.65	35.40	36.73	24.47
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.52	-0.62	-0.68	-0.65	-0.66	-0.67	-0.66	-0.64	-0.64
Leverage Ratio	1.83	1.82	1.72	1.62	1.61	1.55	1.51	1.50	1.48	1.48
Compound Leverage Factor	1.97	1.92	1.75	1.62	1.64	1.62	1.55	1.52	1.49	1.49
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	3.82%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	3.82%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	95.67%	99.50%	99.09%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	-2.24	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	-3.22	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.20	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	10.47	12.22	14.32	16.11	15.08	12.62	12.56	9.83	9.49	8.62
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.25%	0.52%	0.69%	0.47%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.74	2.34	2.20	2.96	3.13	2.94	3.32	3.39	3.42	3.39
Quick Ratio	2.58	2.19	2.09	2.86	3.02	2.84	3.20	3.29	3.25	3.23
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	95	73	69	102	56	54	58	43	34	41
Operating Cash Flow to CapEx	2,082.97%	778.63%	778.93%	1,824.90%	2,071.63%	469.05%	559.50%	1,435.72%	465.13%	1,124.54%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.87	0.81	0.74	0.70	0.81	0.84	0.82	0.80	0.83
Accounts Receivable Turnover	3.40	3.18	3.31	3.71	3.45	3.69	3.52	3.52	3.58	3.58
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	7.53	7.62	8.18	7.78	6.59	7.75	9.36	9.70	9.67	11.03
Accounts Payable Turnover	14.91	12.49	9.86	13.62	14.32	16.34	15.92	16.95	18.73	18.91
Days Sales Outstanding (DSO)	107.43	114.74	110.21	98.41	105.74	98.84	103.83	103.64	101.94	102.06
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	24.48	29.23	37.03	26.80	25.48	22.34	22.93	21.53	19.49	19.30
Cash Conversion Cycle (CCC)	82.95	85.51	73.18	71.61	80.26	76.50	80.89	82.10	82.45	82.76
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	162	169	159	119	133	119	105	93	100	91
Invested Capital Turnover	3.37	3.27	3.68	3.69	3.17	3.72	3.83	3.62	3.30	3.45
Increase / (Decrease) in Invested Capital	-6.77	9.64	40	-14	15	13	13	-6.93	8.41	1.33
Enterprise Value (EV)	4,255	4,217	4,741	5,619	4,258	3,259	2,247	1,523	1,253	1,001
Market Capitalization	4,513	4,404	4,902	5,916	4,486	3,490	2,456	1,719	1,427	1,173
Book Value per Share	$8.29	$7.03	$6.33	$8.00	$6.96	$6.72	$5.98	$11.20	$10.68	$10.21
Tangible Book Value per Share	$8.13	$6.86	$6.16	$7.84	$6.80	$6.56	$5.82	$10.87	$10.34	$9.87
Total Capital	421	356	321	417	376	350	314	289	273	263
Total Debt	0.00	0.00	0.00	0.00	14	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	14	0.00	0.00	0.00	0.00	0.00
Net Debt	-259	-187	-161	-298	-228	-232	-209	-196	-174	-172
Capital Expenditures (CapEx)	6.94	16	12	6.83	4.99	23	16	4.73	14	5.38
Debt-free, Cash-free Net Working Capital (DFCFNWC)	25	30	29	2.09	7.00	8.48	20	26	20	21
Debt-free Net Working Capital (DFNWC)	284	218	190	300	250	240	228	222	194	192
Net Working Capital (NWC)	284	218	190	300	250	240	228	222	194	192
Net Nonoperating Expense (NNE)	-21	-18	6.66	-14	-12	-15	-1.44	-5.24	-4.95	-1.35
Net Nonoperating Obligations (NNO)	-259	-187	-161	-298	-228	-232	-209	-196	-174	-172
Total Depreciation and Amortization (D&A)	9.69	8.92	7.08	6.48	6.71	6.29	6.18	6.29	6.13	6.07
Debt-free, Cash-free Net Working Capital to Revenue	4.44%	5.68%	5.59%	0.45%	1.75%	2.03%	5.21%	7.48%	6.38%	6.62%
Debt-free Net Working Capital to Revenue	50.80%	40.54%	37.04%	64.29%	62.40%	57.55%	60.16%	63.95%	61.51%	61.47%
Net Working Capital to Revenue	50.80%	40.54%	37.04%	64.29%	62.40%	57.55%	60.16%	63.95%	61.51%	61.47%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.13	$1.96	$1.98	$1.92	$1.58	$1.56	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic Shares Outstanding	51.13M	51.15M	51.73M	52.61M	52.39M	52.69M	0.00	0.00	0.00	0.00
Adjusted Diluted Earnings per Share	$2.11	$1.94	$1.96	$1.90	$1.55	$1.53	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	51.57M	51.64M	52.28M	53.33M	53.32M	53.88M	0.00	0.00	0.00	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	50.82M	50.56M	50.64M	52.12M	51.80M	51.82M	0.00	0.00	0.00	0.00
Normalized Net Operating Profit after Tax (NOPAT)	88	82	109	88	71	67	71	36	43	42
Normalized NOPAT Margin	15.83%	15.31%	21.23%	18.79%	17.73%	16.15%	18.66%	10.37%	13.50%	13.51%
Pre Tax Income Margin	26.39%	25.32%	25.76%	26.99%	24.24%	24.97%	24.59%	23.72%	21.94%	22.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	53.41%	53.86%	48.12%	42.68%	48.18%	40.63%	37.67%	52.86%	39.56%	35.89%
Augmented Payout Ratio	58.64%	77.99%	200.42%	49.60%	96.70%	67.26%	76.31%	81.75%	91.06%	89.36%

This table displays calculated financial ratios and metrics derived from Exponent's official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/3/2025	9/27/2024	6/28/2024	3/29/2024	12/29/2023	9/29/2023	6/30/2023	3/31/2023	12/30/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.28%	2.21%	0.22%	3.30%	-3.50%	4.84%	7.63%	9.21%	12.20%	9.26%
EBITDA Growth	2.27%	3.61%	8.39%	12.21%	-1.84%	-0.12%	-0.60%	3.72%	3.06%	1.59%
EBIT Growth	2.07%	3.79%	8.05%	11.93%	-3.75%	-2.07%	-1.69%	3.00%	2.14%	1.43%
NOPAT Growth	60.38%	-23.47%	24.08%	-4.03%	-21.32%	-8.93%	-35.53%	-27.98%	-2.19%	10.30%
Net Income Growth	12.71%	6.14%	13.51%	3.50%	-7.08%	0.39%	-0.03%	-1.64%	10.52%	-0.54%
EPS Growth	12.50%	4.17%	14.00%	5.36%	-9.09%	2.13%	2.04%	0.00%	15.79%	2.17%
Operating Cash Flow Growth	-21.40%	33.84%	19.22%	255.63%	75.77%	-24.54%	34.40%	-5.53%	-25.13%	18.03%
Free Cash Flow Firm Growth	765.28%	315.93%	386.37%	464.73%	113.33%	-225.95%	-177.57%	-135.60%	-177.39%	16.59%
Invested Capital Growth	-4.01%	-11.99%	-9.07%	-4.88%	6.05%	26.37%	21.54%	18.04%	33.44%	6.49%
Revenue Q/Q Growth	0.36%	-3.03%	-3.03%	17.93%	-7.83%	-4.91%	-0.06%	10.17%	0.14%	-2.38%
EBITDA Q/Q Growth	-12.68%	-10.44%	-0.46%	31.37%	-11.53%	-6.31%	3.05%	14.93%	-9.98%	-6.77%
EBIT Q/Q Growth	-13.89%	-10.88%	-0.92%	34.23%	-12.44%	-7.22%	2.64%	15.42%	-10.91%	-6.86%
NOPAT Q/Q Growth	9.55%	-28.85%	14.96%	78.99%	-47.73%	15.36%	-11.09%	46.74%	-39.50%	-18.33%
Net Income Q/Q Growth	-9.43%	-10.89%	-3.04%	44.02%	-14.71%	-4.70%	-11.59%	29.30%	-7.85%	-5.10%
EPS Q/Q Growth	-10.00%	-12.28%	-3.39%	47.50%	-16.67%	-4.00%	-10.71%	27.27%	-6.38%	-4.08%
Operating Cash Flow Q/Q Growth	88.64%	-38.53%	363.37%	-85.37%	221.20%	-45.24%	704.88%	-116.52%	37.89%	-2.48%
Free Cash Flow Firm Q/Q Growth	-38.95%	-1.28%	35.32%	961.05%	115.23%	-30.92%	-72.34%	61.21%	-243.91%	-19.36%
Invested Capital Q/Q Growth	-14.90%	0.32%	-7.63%	21.73%	-21.98%	3.65%	-3.38%	35.73%	-7.04%	-0.30%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	42.78%	39.86%	43.46%	37.68%	35.84%	44.49%	40.92%	40.00%	41.70%	50.64%
EBITDA Margin	22.84%	26.25%	28.42%	27.68%	24.85%	25.89%	26.28%	25.48%	24.43%	27.18%
Operating Margin	19.93%	18.97%	25.43%	21.19%	14.97%	25.45%	21.31%	20.75%	17.30%	28.95%
EBIT Margin	21.02%	24.49%	26.65%	26.08%	22.91%	24.12%	24.72%	24.07%	22.97%	25.82%
Profit (Net Income) Margin	17.25%	19.11%	20.80%	20.80%	17.03%	18.40%	18.36%	20.76%	17.69%	19.22%
Tax Burden Percent	75.30%	72.47%	73.65%	74.57%	69.56%	72.13%	71.02%	81.95%	73.80%	73.01%
Interest Burden Percent	108.99%	107.67%	105.96%	106.95%	106.85%	105.78%	104.60%	105.24%	104.31%	101.94%
Effective Tax Rate	24.70%	27.53%	26.35%	25.43%	30.44%	27.87%	28.98%	18.05%	26.20%	26.99%
Return on Invested Capital (ROIC)	50.62%	36.78%	50.88%	40.56%	34.05%	51.23%	42.53%	44.73%	47.04%	63.53%
ROIC Less NNEP Spread (ROIC-NNEP)	49.24%	32.68%	49.23%	35.64%	29.38%	51.19%	39.64%	41.53%	44.31%	64.78%
Return on Net Nonoperating Assets (RNNOA)	-28.26%	-15.26%	-23.06%	-14.65%	-15.13%	-21.70%	-17.91%	-18.76%	-27.58%	-35.08%
Return on Equity (ROE)	22.36%	21.51%	27.82%	25.91%	18.92%	29.53%	24.62%	25.97%	19.46%	28.45%
Cash Return on Invested Capital (CROIC)	57.50%	52.33%	52.80%	43.55%	44.21%	21.03%	26.97%	33.81%	49.57%	59.48%
Operating Return on Assets (OROA)	16.49%	19.81%	21.98%	23.61%	19.94%	22.48%	22.59%	21.35%	18.56%	21.54%
Return on Assets (ROA)	13.53%	15.46%	17.15%	18.83%	14.82%	17.15%	16.78%	18.41%	14.29%	16.03%
Return on Common Equity (ROCE)	22.36%	21.51%	27.82%	25.91%	18.92%	29.53%	24.62%	25.97%	19.46%	28.37%
Return on Equity Simple (ROE_SIMPLE)	0.00%	25.92%	26.66%	27.08%	0.00%	28.82%	28.52%	29.79%	0.00%	31.33%
Net Operating Profit after Tax (NOPAT)	21	19	26	23	13	24	21	24	16	27
NOPAT Margin	15.00%	13.75%	18.73%	15.80%	10.41%	18.36%	15.13%	17.01%	12.77%	21.13%
Net Nonoperating Expense Percent (NNEP)	1.38%	4.10%	1.65%	4.92%	4.67%	0.04%	2.89%	3.20%	2.73%	-1.24%
Return On Investment Capital (ROIC_SIMPLE)	4.87%	-	-	-	3.59%	-	-	-	5.07%	-
Cost of Revenue to Revenue	57.22%	60.14%	56.54%	62.32%	64.16%	55.51%	59.08%	60.00%	58.30%	49.36%
SG&A Expenses to Revenue	13.34%	12.68%	12.26%	11.15%	13.52%	12.76%	12.08%	10.98%	12.80%	12.23%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.85%	20.90%	18.02%	16.49%	20.87%	19.04%	19.62%	19.25%	24.39%	21.69%
Earnings before Interest and Taxes (EBIT)	29	33	37	38	28	32	35	34	29	33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	31	36	40	40	31	35	37	36	31	35
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	10.72	14.00	12.26	11.15	12.37	12.16	13.12	14.55	15.28	13.73
Price to Tangible Book Value (P/TBV)	10.94	14.30	12.53	11.41	12.67	12.46	13.44	14.92	15.71	14.11
Price to Revenue (P/Rev)	8.08	10.55	8.90	7.71	8.20	7.94	8.76	9.47	9.55	8.79
Price to Earnings (P/E)	41.41	54.03	45.97	41.18	43.89	42.18	46.01	48.82	47.91	43.84
Dividend Yield	1.26%	0.97%	1.14%	1.29%	1.20%	1.21%	1.09%	1.00%	0.99%	1.07%
Earnings Yield	2.42%	1.85%	2.18%	2.43%	2.28%	2.37%	2.17%	2.05%	2.09%	2.28%
Enterprise Value to Invested Capital (EV/IC)	26.24	29.00	24.30	19.48	24.96	19.22	21.72	22.42	29.76	24.77
Enterprise Value to Revenue (EV/Rev)	7.62	10.15	8.52	7.40	7.86	7.69	8.48	9.23	9.24	8.50
Enterprise Value to EBITDA (EV/EBITDA)	28.93	37.75	31.81	28.20	30.63	30.11	32.81	35.00	34.55	31.14
Enterprise Value to EBIT (EV/EBIT)	30.97	40.40	34.05	30.16	32.75	32.06	34.76	36.97	36.43	32.77
Enterprise Value to NOPAT (EV/NOPAT)	48.11	68.59	53.46	49.27	51.30	48.43	51.33	48.21	43.50	38.84
Enterprise Value to Operating Cash Flow (EV/OCF)	29.44	34.58	30.32	27.72	33.11	43.09	43.69	51.86	50.54	39.51
Enterprise Value to Free Cash Flow (EV/FCFF)	44.69	51.87	43.84	43.60	58.12	102.07	88.35	71.80	68.63	42.94
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.47	-0.47	-0.41	-0.52	-0.42	-0.45	-0.45	-0.62	-0.54
Leverage Ratio	1.83	1.76	1.75	1.67	1.82	1.72	1.69	1.63	1.72	1.65
Compound Leverage Factor	2.00	1.90	1.85	1.79	1.95	1.82	1.76	1.71	1.80	1.68
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	10.01	12.81	11.72	12.64	11.71	13.18	14.17	16.19	13.75	13.82
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.28%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.74	3.00	2.97	3.09	2.34	2.65	2.77	2.92	2.20	2.41
Quick Ratio	2.58	2.82	2.80	2.91	2.19	2.46	2.60	2.74	2.09	2.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	27	45	45	33	3.15	-21	-16	-9.17	-24	16
Operating Cash Flow to CapEx	2,158.34%	1,733.61%	4,218.06%	703.91%	3,687.13%	671.54%	744.22%	-118.26%	1,382.28%	921.13%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.81	0.82	0.91	0.87	0.93	0.91	0.89	0.81	0.83
Accounts Receivable Turnover	3.40	3.11	3.17	3.22	3.18	3.11	3.17	3.28	3.31	3.22
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	7.53	7.31	7.23	7.52	7.62	7.70	7.61	8.05	8.18	8.03
Accounts Payable Turnover	14.91	15.64	15.27	12.98	12.49	12.25	13.08	9.78	9.86	9.67
Days Sales Outstanding (DSO)	107.43	117.40	115.12	113.25	114.74	117.27	115.15	111.41	110.21	113.30
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	24.48	23.34	23.90	28.13	29.23	29.79	27.91	37.30	37.03	37.75
Cash Conversion Cycle (CCC)	82.95	94.06	91.22	85.12	85.51	87.48	87.24	74.11	73.18	75.55
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	162	191	190	206	169	217	209	216	159	171
Invested Capital Turnover	3.37	2.68	2.72	2.57	3.27	2.79	2.81	2.63	3.68	3.01
Increase / (Decrease) in Invested Capital	-6.77	-26	-19	-11	9.64	45	37	33	40	10
Enterprise Value (EV)	4,255	5,526	4,616	4,005	4,217	4,163	4,537	4,847	4,741	4,244
Market Capitalization	4,513	5,745	4,820	4,174	4,404	4,300	4,685	4,973	4,902	4,392
Book Value per Share	$8.29	$8.09	$7.76	$7.34	$7.03	$6.95	$7.02	$6.75	$6.33	$6.26
Tangible Book Value per Share	$8.13	$7.92	$7.59	$7.17	$6.86	$6.79	$6.85	$6.58	$6.16	$6.09
Total Capital	421	410	393	374	356	354	357	342	321	320
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-259	-220	-203	-169	-187	-137	-148	-126	-161	-148
Capital Expenditures (CapEx)	2.60	1.71	1.15	1.48	1.93	3.31	5.45	5.67	2.94	3.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)	25	55	56	70	30	77	72	83	29	46
Debt-free Net Working Capital (DFNWC)	284	275	260	238	218	214	220	209	190	195
Net Working Capital (NWC)	284	275	260	238	218	214	220	209	190	195
Net Nonoperating Expense (NNE)	-3.07	-7.31	-2.90	-7.24	-8.13	-0.06	-4.53	-5.26	-6.26	2.44
Net Nonoperating Obligations (NNO)	-259	-220	-203	-169	-187	-137	-148	-126	-161	-148
Total Depreciation and Amortization (D&A)	2.49	2.39	2.49	2.32	2.38	2.36	2.19	1.99	1.86	1.72
Debt-free, Cash-free Net Working Capital to Revenue	4.44%	10.12%	10.38%	12.84%	5.68%	14.15%	13.44%	15.90%	5.59%	9.24%
Debt-free Net Working Capital to Revenue	50.80%	50.46%	47.90%	44.00%	40.54%	39.48%	41.13%	39.82%	37.04%	38.96%
Net Working Capital to Revenue	50.80%	50.46%	47.90%	44.00%	40.54%	39.48%	41.13%	39.82%	37.04%	38.96%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.46	$0.51	$0.57	$0.59	$0.41	$0.48	$0.50	$0.57	$0.45	$0.47
Adjusted Weighted Average Basic Shares Outstanding	51.13M	51.18M	51.11M	51.01M	51.15M	51.20M	51.26M	51.13M	51.73M	51.49M
Adjusted Diluted Earnings per Share	$0.45	$0.50	$0.57	$0.59	$0.40	$0.48	$0.50	$0.56	$0.44	$0.47
Adjusted Weighted Average Diluted Shares Outstanding	51.57M	51.62M	51.52M	51.42M	51.64M	51.65M	51.69M	51.68M	52.28M	52.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	50.82M	50.76M	50.73M	50.67M	50.56M	50.62M	50.85M	50.84M	50.64M	50.64M
Normalized Net Operating Profit after Tax (NOPAT)	21	19	26	23	13	24	21	24	16	27
Normalized NOPAT Margin	15.00%	13.75%	18.73%	15.80%	10.41%	18.36%	15.13%	17.01%	12.77%	21.13%
Pre Tax Income Margin	22.91%	26.37%	28.24%	27.89%	24.48%	25.51%	25.85%	25.33%	23.96%	26.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	53.41%	53.73%	53.51%	54.39%	53.86%	52.04%	51.15%	50.30%	48.12%	47.42%
Augmented Payout Ratio	58.64%	65.90%	82.05%	83.66%	77.99%	82.09%	94.37%	155.65%	200.42%	189.35%

Frequently Asked Questions About Exponent's Financials

When does Exponent's fiscal year end?

According to the most recent income statement we have on file, Exponent's financial year ends in January. Their financial year 2025 ended on January 3, 2025.

How has Exponent's net income changed over the last 9 years?

Exponent's net income appears to be on an upward trend, with a most recent value of $109.00 million in 2024, rising from $43.60 million in 2015. The previous period was $100.34 million in 2023. See Exponent's forecast for analyst expectations on what’s next for the company.

What is Exponent's operating income?

Exponent's total operating income in 2024 was $119.56 million, based on the following breakdown:

Total Gross Profit: $228.50 million
Total Operating Expenses: $108.95 million

How has Exponent revenue changed over the last 9 years?

Over the last 9 years, Exponent's total revenue changed from $312.83 million in 2015 to $558.51 million in 2024, a change of 78.5%.

How much debt does Exponent have?

Exponent's total liabilities were at $356.20 million at the end of 2024, a 22.5% increase from 2023, and a 185.6% increase since 2015.

How much cash does Exponent have?

In the past 9 years, Exponent's cash and equivalents has ranged from $114.97 million in 2016 to $297.69 million in 2021, and is currently $258.90 million as of their latest financial filing in 2024.

How has Exponent's book value per share changed over the last 9 years?

Over the last 9 years, Exponent's book value per share changed from 10.21 in 2015 to 8.29 in 2024, a change of -18.7%.

Related Companies

This page (NASDAQ:EXPO) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exponent (EXPO) Financials

Frequently Asked Questions About Exponent's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Exponent (EXPO) Financials

Annual Income Statements for Exponent

Quarterly Income Statements for Exponent

Annual Cash Flow Statements for Exponent

Quarterly Cash Flow Statements for Exponent

Annual Balance Sheets for Exponent

Quarterly Balance Sheets for Exponent

Annual Metrics And Ratios for Exponent

Quarterly Metrics And Ratios for Exponent

Frequently Asked Questions About Exponent's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools